Caraco

The case pertains to Sun Pharma's US subsidiary Caraco. The US Circuit Court of Appeals ruled that Caraco did not comply with norms while closing two of its units in Detroit and Farmington Hills.

USFDA ban may not affect Sun Pharma financially: JM Fin

However, softer issues may possibly drag the management bandwidth as this is the first time the company has received an import alert.

Sun Pharma trips 6% on USFDA import alert for Karkhadi unit

Shares of Sun Pharmaceutical Industries fell more than 6 percent intraday Thursday on getting USFDA import alert for its Karkhadi unit.

Sun Pharma up 3%, arm gets USFDA nod for schizophrenia drug

Caraco has received approval from US Food and Drug Administration (FDA) for Risperidone oral tablets.

What to expect from Sun Pharma in Q4

Sun Pharmaceutical Indusries' fourth quarter revenues may rise by 26 percent year-on-year to Rs 2,946 crore during the March quarter.

Caraco completes tender offer to acquire Dusa Pharma

Drug firm Sun Pharmaceutical Industries today said its US-based subsidiary Caraco has successfully completed the tender offer to acquire Dusa Pharmaceuticals.

Sun Pharma arm Caraco gets US FDA nod to resume operations

Sun Pharmaceutical Industries on Tuesday said its subsidiary Caraco has received clearance from US Food and Drugs Administration to resume operations at its manufacturing facility and packaging sites at Detroit and Wixom, in Michigan, United States and start production of two drugs.

Sun Pharma rises 1% as Caraco gets USFDA clearance

Drug producer Sun Pharmaceutical Industries gained nearly 1% on Tuesday as the company said its subsidiary Caraco has received US FDA clearance to resume operations at its manufacturing facility and packaging sites in Detriot and Wixom, Michigan.

US top court rules for Sun Pharma unit on patent

The US Supreme Court ruled on Tuesday in favor of a generic drugmaker in a case over how companies can fight brand-name rivals in an effort to get their cheaper medicines to market.